Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Progeria Progress: Studies Show How Mutant Protein Hurts Hearts

20.02.2006


Two new research studies on progeria, published in the Proceedings of the National Academy of Sciences, detail the damage a mutant protein does to blood vessel cells of humans and mice. The discoveries offer increased hope for a cure for progeria, a genetic condition fatal in children, but may also provide key insight into the cause of adult heart disease.



In children with progeria, a mutant protein accumulates in blood vessel cells, hampering their ability to grow and multiply or killing them outright. In mice that produce this same toxic protein, the effect is similar: These vascular cells become damaged or die.

These are the findings of two research reports published in the Proceedings of the National Academy of Sciences. Both shed important new light on the progression of progeria, a rare and fatal genetic condition that causes accelerated aging in children. But they may also illuminate the cause of atherosclerosis in adults. Also known as hardening of the arteries, atherosclerosis is a leading cause of heart attacks and strokes.


“These are very important findings not only for children with progeria but potentially for millions of adults,” said Leslie B. Gordon, M.D., Ph.D., assistant professor of pediatrics research at Brown Medical School and a co-author on both research papers.

“We now know there is a brand-new culprit molecule that plays a pivotal role in causing heart disease,” Gordon said. “We know this is true with progeria. Now we can explore a bigger question: Does this molecule play the same role in heart disease in all of us?”

A Brown Medical School graduate, Gordon created the Progeria Research Foundation in 1999, one year after her son, Sam, was diagnosed with the condition. The foundation raises public awareness and bankrolls research about the rare disorder, which causes hair loss, osteoporosis, and other signs of premature aging in children. Children with the disorder die almost exclusively of atheroscleroris at an average age of 13. This form of heart disease is typically seen in people over 60.

Progeria is extremely rare. The foundation reports that there are 42 known cases worldwide. Atherosclerosis, however, is quite common, affecting millions of adults. It prompts the build-up of fats, cholesterol, calcium and other substances in arteries. These plaques reduce blood flow and can cause clots that block blood vessels to the heart or brain, triggering a heart attack or stroke.

To better understand progeria, and find a cure, the foundation runs a medical and research database through Brown’s Center for Gerontology and Health Care Research and operates a cell and tissue bank at Rhode Island Hospital. It also funds research, providing partial funding for one of the new research studies.

Here are summaries of those reports:

>>> Using human skin tissue from the Rhode Island Hospital bank, researchers from the College of Physicians and Surgeons at Columbia University found that progerin, a mutant form of the protein lamin A, builds up in the nucleus of cells, particularly those of blood vessels. As a result of this build-up, the nucleus becomes deformed and these cells stop growing, moving and multiplying. Some cells die. Blood vessel cells most affected were those in smooth muscle. The result is support for a direct relationship between progerin and atherosclerosis. The results of this study replicate findings included in previous research on the use of FTIs in progeria research.

>>> A research team, led by scientists at the National Human Genome Research Institute at the National Institutes of Health, created and studied mice that carried the human form of the mutant lamin A gene. The gene, harbored in an artificial chromosome, produced the same toxic protein that harms or kills cells in children with progeria. In parallel with the Columbia and Brown team, scientists found that these mice lost blood vessel cells in smooth muscle.

“This mouse model should prove valuable for testing experimental therapies for progeria, such as anti-cancer drugs and bone marrow transplants,” said Francis S. Collins, M.D., director of the National Human Genome Research Institute and senior scientist on the NIH paper. “Now that we’re armed with a better understanding of the underlying causes of atherosclerosis, we can also use this model to explore cardiovascular disease in general.”

The Progeria Research Foundation and the National Institutes of Health funded the Columbia-led research. The National Institutes of Health, the Tore Nilsson Foundation, the Ake Wiberg Foundation, the Hagelen Foundation, the Loo and Hans Osterman Foundation, the Torsten and Ragnar Soderberg Foundation, the Jeansson Foundation, the Swedish Research Foundation and the Swedish Foundation for Strategic Research funded the experiments overseen by the National Human Genome Research Institute.

Copies of both articles can be found at the website of the Proceedings of the National Academies of Science at www.pnas.org. For more information on progeria, visit genome.gov/11007255 or www.progeriaresearch.org.

Wendy Lawton | EurekAlert!
Further information:
http://www.progeriaresearch.org
http://genome.gov/11007255
http://www.pnas.org

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>